Cell
Volume 56, Issue 5, 10 March 1989, Pages 839-847
Journal home page for Cell

Article
The major human rhinovirus receptor is ICAM-1

https://doi.org/10.1016/0092-8674(89)90688-0Get rights and content

Abstract

The major human rhinovirus receptor has been identified with monoclonal antibodies that inhibit rhinovirus infection. These monoclonal antibodies recognize a 95 kd cell surface glycoprotein on human cells and on mouse transfectants expressing a rhinovirus binding phenotype. Purified 95 kd protein binds to rhinovirus in vitro. Protein sequence from the 95 kd protein showed an identity with that of intercellular adhesion molecule-1 (ICAM-1); a cDNA clone obtained from mouse transfectants expressing the rhinovirus receptor had essentially the same sequence as ICAM-1. Thus, the major human rhinovirus receptor is ICAM-1. The gene for this receptor maps to human chromosome 19, which also contains the genes for a number of other picornavirus receptors.

References (50)

  • P. Parham

    Monoclonal antibodies against HLA products and their use in immunoaffinity chromatography

    Meth. Enzymol.

    (1983)
  • M.G. Rossmann et al.

    Conservation of the putative receptor attachment site in picornaviruses

    Virology

    (1988)
  • T. Siddique et al.

    The poliovirus sensitivity (PVS) gene is on chromosome 19q12-q13.2

    Genomics

    (1988)
  • D.E. Staunton et al.

    Primary structure of intercellular adhesion molecule 1 (ICAM-1) demonstrates interaction between members of the immunoglobulin and integrin supergene families

    Cell

    (1988)
  • G. Von Heijne

    How signal sequences maintain cleavage specificity

    J. Mol. Biol.

    (1984)
  • G. Abraham et al.

    Many rhinovirus serotypes share the same cellular receptor

    J. Virol.

    (1984)
  • G. Abraham et al.

    Characterization of human rhinoviruses displaced by an anti-receptor monoclonal antibody

    J. Virol.

    (1988)
  • P.L. Callahan et al.

    Molecular cloning and complete sequence determination of RNA genome of human rhinovirus type 14

    J. Virol.

    (1985)
  • M. Chow et al.

    Myristylation of picornavirus capsid protein VP4 and its structural significance

    Nature

    (1987)
  • R.J. Colonno et al.

    Isolation of a monoclonal antibody that blocks attachment of the major group of rhinoviruses

    J. Virol.

    (1986)
  • P. Couillin et al.

    Echovirus 6, 11, 19; coxsackie B3 sensitivities and poliovirus I, II, III sensitivities are on chromosome 19 respectively on 19pter-q133 and 19q131-q133

    Cytogenet. Cell Genet.

    (1987)
  • R.L. Crowell et al.

    Monoclonal antibody that inhibits infection of HeLa and rhabdomyosarcoma cells by selected enteroviruses through receptor blockade

    J. Virol.

    (1986)
  • P.E. Devlin et al.

    Southern analysis of genomic DNA with unique and degenerate oligonucleotide probes: a method for reducing probe degeneracy

    DNA

    (1988)
  • M. Duechler et al.

    Evolutionary relationships within the human rhinovirus genus: comparison of serotypes 89, 2 and 14

  • M. Dustin et al.

    Induction by IL-1 and interferon: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1)

    J. Immunol.

    (1986)
  • Cited by (971)

    • Enterovirus entry and uncoating

      2023, Molecular Medical Microbiology, Third Edition
    • Airway epithelial cell-specific delivery of lipid nanoparticles loading siRNA for asthma treatment

      2022, Journal of Controlled Release
      Citation Excerpt :

      Studies have demonstrated that AECs express increased levels of surface markers and receptors associated with inflammatory cell infiltration and airway remodeling in asthmatic inflammatory conditions [18]. Among these surface markers, intercellular adhesion molecule-1 (ICAM-1), also known as CD54, is upregulated by inflammatory stimuli in asthma, and its expression level correlates with severity of the disease [19,20]. In fact, ICAM-1 plays an important role in cell adhesion and migration and serves as a principal receptor for the majority of rhinoviruses (RVs), which has been exploited as a target to design drug delivery vehicles for site-specific delivery of therapeutic agents into AECs [21–24].

    • Sphingosine Prevents Rhinoviral Infections

      2024, International Journal of Molecular Sciences
    View all citing articles on Scopus
    View full text